News

Covation Biomaterials starts commercial Xatryx production

09/09/2026

Polymer developer Covation Biomaterials has begun commercial production of its Xatryx bioTHF and bioPTMEG materials at its new 50,000-tonne Qidong plant in China.

The company said the first commercial batches, produced in August, met industry-standard specifications across three bioPTMEG molecular weight grades.

To continue reading this story, please sign in or register.

Related stories:

Bio-based PTMEG alternative announced by Covation Biomaterials 16/04/2025
Midsole in new Saucony shoe has 55% plant-based content 12/09/2023
Plant-based is not enough, Covation Biomaterials says 20/10/2022

Footwearbiz.com cannot be held responsible for content if the language setting is changed from English.

The translations provided by Google Translate are automated and therefore might not be accurate and may contain incorrect, offensive or misleading language. We offer this facility as a guide only.